Rituximab, Mabthera ( DrugBank: Rituximab )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
53	シェーグレン症候群	1

53. シェーグレン症候群

---

臨床試験数 : 305 /  薬物数 : 325 - (DrugBank : 104) / 標的遺伝子数 : 58 - 標的パスウェイ数 : 188

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00426543 (ClinicalTrials.gov)	January 2007	23/1/2007	Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome	Phase 1 Study of B-cell Depletion With Rituximab on Oral, Ocular and General Disease Manifestations in Patients With Primary Sjögren's Syndrome	Primary Sjögren's Syndrome;Xerostomia;Hyposalivation;Keratoconjunctivitis Sicca;Fatigue	Drug: MabThera (rituximab);Drug: Rituximab, Mabthera	University of Copenhagen	Rigshospitalet, Denmark	Completed	18 Years	70 Years	Female	21	Phase 2	Denmark